Archive Newsletter
-
03.18.24 -- Bringing Therapies To Patients With Speed And Confidence
3/18/2024
03/18/24 Cell & Gene Newsletter
-
03.18.24 -- Reducing Batch-To-Batch Variation In Cell Therapy Manufacturing
3/18/2024
03/18/24 Cell & Gene Newsletter
-
03.14.24 -- Explore Revolutionary Research Shaping Medicine
3/14/2024
03/14/24 Cell & Gene Newsletter
-
03.14.24 -- mRNA: Challenges & Opportunities For Scale-Out, Optimization
3/14/2024
03/14/24 Cell & Gene Newsletter
-
03.13.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
3/13/2024
03/13/24 Cell & Gene Newsletter
-
03.13.24 -- Human Genome Editing: New Implications & Remaining Questions
3/13/2024
03/13/24 Cell & Gene Newsletter
-
03.12.24 -- Examining The 2024 Regulatory Landscape Of CGT
3/12/2024
03/12/24 Cell & Gene Newsletter
-
03.11.24 -- Overcoming Advanced Therapy Development Hurdles
3/11/2024
03/11/24 Cell & Gene Newsletter
-
03.11.24 -- Cell And Gene: Regulating Rare Disease Study Design
3/11/2024
03/11/24 Cell & Gene Newsletter
-
03.08.24 -- New Episodes: Yescarta's Reduced Median Turnaround Time, Inhalable mRNA and more!
3/8/2024
03/08/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more